Target Name: DYSF
NCBI ID: G8291
Other Name(s): Fer-1-like protein 1 | Limb girdle muscular dystrophy 2B (autosomal recessive) | FER1L1 | Dysferlin (isoform 12) | dystrophy-associated fer-1-like 1 | LGMD2B | DYSF variant 8 | Dysferlin, transcript variant 1 | DYSF variant 13 | DYSF variant 2 | Fer-1-like family member 1 | fer-1-like protein 1 | Dystrophy-associated fer-1-like protein | LGMDR2 | MMD1 | DYSF variant 9 | Dysferlin (isoform 13) | Dysferlin, transcript variant 13 | limb girdle muscular dystrophy 2B (autosomal recessive) | dysferlin | Dysferlin, transcript variant 4 | fer-1-like family member 1 | Dysferlin, transcript variant 2 | DYSF_HUMAN | DYSF variant 1 | DYSF variant 12 | Dysferlin, transcript variant 8 | Dysferlin, transcript variant 9 | Dysferlin | Dysferlin, transcript variant 12 | DYSF variant 4 | Dystrophy-associated fer-1-like 1

Study of DYSF: Unlocking The Potential of Ferulin-Like Proteins

DYSF (Fer-1-like protein 1) is a protein that is expressed in a variety of tissues throughout the body, including the heart, lungs, kidneys, and intestines. It is a member of the ferulin protein family, which includes a number of similar proteins that are involved in various cellular processes, including signaling, DNA replication, and cellular signaling pathways.

One of the unique features of DYSF is its ability to form aggregates in culture, which allows it to be easily isolated and purified. This has made DYSF a useful tool for studying the biology of these proteins, particularly their role in diseases such as cancer, neurodegenerative diseases, and cardiovascular disease.

In addition to its unusual ability to form aggregates, DYSF is also notable for its role in several cellular signaling pathways. For example, DYSF has been shown to be involved in the regulation of theNotch signaling pathway, a pathway that is involved in the development and maintenance of tissues and organs.

DYSF has also been shown to be involved in the regulation of the Wnt signaling pathway, a pathway that is involved in the development and maintenance of tissues and organs. This pathway is important for the development and maintenance of tissues such as the brain and nervous system, and is often disrupted in a variety of diseases, including cancer.

In addition to its role in these signaling pathways, DYSF has also been shown to be involved in the regulation of a variety of cellular processes, including cell division, apoptosis (programmed cell death), and inflammation.

DYSF has also been shown to be involved in the regulation of cell division, which is important for the growth and development of tissues and organs. It has also been shown to be involved in the regulation of apoptosis, which is the process by which cells die when they are no longer needed.

In addition to its role in these processes, DYSF has also been shown to be involved in the regulation of inflammation. This is important for the immune response and for the regulation of tissue repair and regeneration.

DYSF is also of interest as a potential drug target. Its unique ability to form aggregates and its involvement in several cellular signaling pathways make it a potential target for small molecules. In addition, its involvement in the regulation of cell division, apoptosis, and inflammation makes it a potential target for drugs that are used to treat these conditions.

Overall, DYSF is a protein that has significant potential as a drug target or biomarker. Its unique ability to form aggregates and its involvement in several cellular signaling pathways make it a valuable tool for the study of these processes and their role in diseases. Further research is needed to fully understand the role of DYSF in these processes and its potential as a drug target.

Protein Name: Dysferlin

Functions: Key calcium ion sensor involved in the Ca(2+)-triggered synaptic vesicle-plasma membrane fusion. Plays a role in the sarcolemma repair mechanism of both skeletal muscle and cardiomyocytes that permits rapid resealing of membranes disrupted by mechanical stress (By similarity)

More Common Targets

Dystrophin-Associated Glycoprotein Complex | DYTN | DZANK1 | DZIP1 | DZIP1L | DZIP3 | E2F Transcription Factor | E2F-6 complex | E2F1 | E2F2 | E2F3 | E2F4 | E2F5 | E2F6 | E2F6P4 | E2F7 | E2F8 | E3 ubiquitin-protein ligase | E4F1 | EAF1 | EAF2 | EAPP | Early growth response | EARS2 | EBAG9 | EBF1 | EBF2 | EBF3 | EBF4 | EBI3 | EBLN1 | EBLN2 | EBLN3P | EBNA1BP2 | EBP | EBPL | ECD | ECE1 | ECE1-AS1 | ECE2 | ECEL1 | ECEL1P1 | ECEL1P2 | ECH1 | ECHDC1 | ECHDC2 | ECHDC3 | ECHS1 | ECI1 | ECI2 | ECI2-DT | ECM1 | ECM2 | ECPAS | ECRG4 | ECSCR | ECSIT | ECT2 | ECT2L | Ectonucleoside triphosphate diphosphohydrolase | EDA | EDA2R | EDAR | EDARADD | EDC3 | EDC4 | EDDM3A | EDDM3B | EDEM1 | EDEM2 | EDEM3 | EDF1 | EDIL3 | EDIL3-DT | EDN1 | EDN2 | EDN3 | EDNRA | EDNRB | EDNRB-AS1 | EDRF1 | EDRF1-AS1 | EDRF1-DT | EEA1 | EED | EEF1A1 | EEF1A1P11 | EEF1A1P14 | EEF1A1P19 | EEF1A1P22 | EEF1A1P25 | EEF1A1P28 | EEF1A1P3 | EEF1A1P30 | EEF1A1P38 | EEF1A1P44 | EEF1A1P47 | EEF1A1P5 | EEF1A1P6 | EEF1A1P9